Last updated 2026-06-18
- Acquired by OPKO Health, Aug 2013
Total raised
—
Stage
Acquired
Founded
2005
Headcount
31
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
PROLOR Biotech, develops proprietary versions of therapeutic proteins and peptide drugs already approved for medical therapy, such as human growth hormone. The company's goal is to create longer-acting versions of existing therapies that could be administered, for example, by injection once a week rather than having to be administered daily. The company's three primary products are designed to treat growth hormone deficiency, hemophilia, and type 2 diabetes.
Q&A
- What is PROLOR Biotech's primary business?
- PROLOR Biotech develops proprietary, longer-acting versions of existing therapeutic proteins and peptide drugs, aiming to reduce administration frequency for treatments like human growth hormone.
- When was PROLOR Biotech founded?
- PROLOR Biotech was founded in January 2005.
- What is the current status of PROLOR Biotech?
- PROLOR Biotech was acquired by OPKO Health in August 2013 and is currently inactive.
- Which company acquired PROLOR Biotech?
- PROLOR Biotech was acquired by OPKO Health in August 2013.
- What are the main product areas PROLOR Biotech focused on?
- PROLOR Biotech's primary products were designed to treat growth hormone deficiency, hemophilia, and type 2 diabetes.
- In which sector does PROLOR Biotech operate?
- PROLOR Biotech operates in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology and Drugs Discovery & Development.
- How many employees did PROLOR Biotech have at the time of its acquisition?
- PROLOR Biotech had an employee count in the 11-50 range.
- Where is PROLOR Biotech's headquarters located?
- PROLOR Biotech's headquarters is located in Ness Ziona, Center District, Israel.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
proteinstherapeuticsbiopharmaceuticalobesitybiotechnology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2005-1 |
|---|---|
| Employees (exact) | 31 |
| Status reason | Acquired (Inactive) by OPKO Health on Aug 2013 - closed due to acquisition |
Acquisitions & public offerings
Acquired by OPKO Health 2013-08
Radar intelligence
Patents
| EPO | 18 |
|---|